Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

NCT03694002 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

NETWORK

Sponsor class

Conditions

Locally Advanced Thymic Carcinoma
Metastatic Thymic Carcinoma
Recurrent Thymic Carcinoma
Unresectable Thymic Carcinoma

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
BIOLOGICAL: Ramucirumab

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]